Investigators pooled data from patients from 3 phase 3, 24-week, randomized, placebo-controlled trials of MEM in patients with Alzheimer disease receiving concurrent ChEIs.
All articles by Alicia Ciccone, Digital Content Editor
While hundreds of published reports have made an argument for an association between Alzheimer disease and bacteria and viruses, the suggestion of a viral contribution to Alzheimer disease has not always been well received by the greater research community.
In order to maximize cognitive benefits in patients with epilepsy, early consideration of and evaluation for epilepsy surgery is key.
Primary hyperparathyroidism may be linked to lower intracerebral vasomotor reactivity, which could lead to cognitive dysfunction.
Anxiety and severe cognitive fatigue may contribute to problems with visual learning in patients with MS.
Ingrezza significantly and rapidly improved tardive dyskinesia symptoms compared to placebo, rmarking a tremendous breakthrough for patients suffering from TD.
Addressing problems with sleep health may help prevent gestational diabetes.
Migraine was more significantly associated with muscle soreness or pain than anxiety disorders in patients with MDD.
Eli Lilly’s investigational Alzheimer’s drug did not meet the primary end point in the phase 3 EXPEDITION3 trial.
Latest News Your top articles for Saturday
Haymarket Medical NetworkTop Picks